Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCOTROC 1: Paclitaxel-Carboplatin vs Docetaxel-Carboplatin in Ovarian Cancer
NCT00003998Phase 3Completed
- Sponsor
- University of Glasgow
- Start
- Oct 1998
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of docetaxel in ovarian epithelial cancer and primary peritoneal cancer (PPC) (2 arms), sponsored by University of Glasgow. Primary endpoint: Progression-Free Survival. Started Oct 1998; status: completed.
02
Drugs
docetaxel
03
Conditions
ovarian epithelial cancerprimary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT00003998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003998.